Form4insider filings, from the source

SEC Form 4 · accession 0001437749-15-009012

HYPERION THERAPEUTICS INC · HPTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Donald J Santel
Officer — CEO & President · Director
Period of report
May 1, 2015
Accepted (ET)
May 5, 2015 · 5:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386858

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 1, 2015M224,211$1.28A280,689D
Common StockMay 1, 2015M33,242$4.08A313,931D
Common StockMay 1, 2015M34,604$7.31A348,535D
Common Stockholding———10,164IBy Donald J. Santel and Kelly L. McGinnis, Trust UA. dated 12/18/08 FBO Margaret Cate Santel

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F1$1.28May 1, 2015M224,211D—Nov 2, 2019Common Stock224,211303,133D
Employee Stock Option (right to buy)F1$4.08May 1, 2015M33,242D—Apr 14, 2021Common Stock33,2426,648D
Employee Stock Option (right to buy)F1$7.31May 1, 2015M34,604D—Apr 15, 2022Common Stock34,60488,547D

Explanation of responses